 | This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Dr. Jonas Moses new article content ...
Scientist, Innovator, Futurist, Author and Entrepreneur, Dr. Jonas Moses, is the Founder and CSO of notopos Corporation (dba notopos univers)[1]. Dr. Moses is also the Founder and Executive Producer of On the Edge Productions LLC and Director/Host of the television series, “On the Edge.”[2] He has been called “a visionary innovator, who’s assumed a leadership role” in the development of novel medical, scientific and technological devices, therapeutics, diagnostics, processes and procedures.[3]
Dr. Moses began his professional career working in the Life Sciences, Environmental Engineering and clinical Medicine and has been involved in diverse medical-, scientific- and technology-related industries. He has consulted with scientists, physicians, governmental leaders, policy-makers, industry professionals and academes, throughout the United States, Eastern and Western Europe, Africa, Asia, South America and Australia. Dr. Moses has spoken on a broad spectrum of Innovation, Technology and Public Policy subjects, before diverse professional audiences across the United States. He has also been interviewed on several syndicated radio talk shows – including his recent appearance on “The Gary Null Show” (broadcast over National Public Radio)[4] and the syndicated “Robert Scott Bell Show”[5] – on themes such as “Public Health Policy and Infectious Diseases.”
By training and education, Dr. Moses is a Biomedical Engineer (Ph.D. in Cell and Tissue Engineering), having previously trained in surgery and disease of the eye - (Ophthalmology) during a several-year stint in the United States Army. He received his PhD from the University of Illinois-Chicago, predicated upon his work as a cancer researcher and his subsequent dissertation entitled “Platelets, Cytoplasts and Extra Cellular Matrix in the Bio-Engineering of a 3-Dimensional, In Vitro Tumor Model.”[6] While working on his doctorate, he was also a prolific research scientist, engaged in the cell and developmental biology of cancer. During his tenure at the University of Illinois, Dr. Moses, along with colleagues, concepted and/or developed several patent-worthy innovations.[7]
Although the majority of his background is based in the Sciences, Medicine and Technology, Dr. Moses possesses a substantial fund of corporate knowledge and experience, as he spent several years developing his real-world business skills in the disciplines of strategic planning, organizational development, change management and corporate visioning - having been a consultant to and/or the Founder or Co-Founder of multiple successful ventures.
- ^ see Dun&Bradstreet Corporate Reports: notopos Corporation, a Delaware Corporation, notopos Corporation website, http://www.notopos.com
- ^ On the Edge Productions, http://www.ontheedgestudios.com; InTimeTV, http://intimetv.com/medical/ote.cfm; notopos Channel, http://www.YouTube.com/users/notopos
- ^ Excerpted from a quote by Celia Farber - author, producer and journalist for SPIN, Rolling Stone, Esquire, Harper's, Newsmax, Salon.com, Gear, the New York Press, Red Flags, and others, in reference to a 2008 review of Dr. Moses' television series, "On the Edge,".
- ^ The Gary Null Show – 05/08/09
- ^ The Robert Scott Bell Show, Mon, 20 Apr 2009
- ^ University of Illinois Press (2007)
- ^ 1) “ECM Matrix Bio-assay Chip – a Novel Method of Cancer Detection” (2003, patent-pending); 2) “Compositions and Methods for Multi-dimensional Printing of Cells and Tissues” (2004, patent pending, with Daniel Murauski); 3) “Methods and Compositions for Piercing Studs with Bioactive Polymer Coating” (2004, provisional patent, with Daniel Murauski); 2007, utility patent-pending); 4) “A Novel, Auto-focusing, Intraocular Lens Implant System” (2006, patent-pending) 5) “A Portable, Self-contained and Semi-disposable Bioreactor” (2006, revised patent-pendiong); 6) “IV Secure Split and Separator” (2007, provisional patent, with Daniel Murauski); 7) “Intra-tumoral Micro-Imaging Utilizing Dye-labeled Nanospheres with an Autologous-derived, Bioactive Coating” (2007, patent-pending, with Daniel Murauski) 8) “Intra-tumoral Delivery of Nanospheres imbued with an Autologous-derived, Bioactive Coating, in the Treatment of Neoplasias” (2007, patent-pending, with Daniel Murauski)